Delivery Order SPE2DB20D1109-SPE2DB25FP45T
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Levorphanol 2 mg tablets (100-count units) with a ceiling value of $2.8K. This is a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and represents a non-competitive set-aside award. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,927.24 to Amerisourcebergen Drug Corp's Corporate Office Division to provide 4,564,830,114 tablets of 2 mg Levorphanol, a prescription medication, by June 7, 2024. This contract is part of Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen supplies a comprehensive range...
- The Defense Logistics Agency Troop Support Medical awarded a $3,696.21 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 2 milligram levorphanol tablets. The contract has a period of performance from September 1, 2023 through September 5, 2023, with all work to be performed by the prime contractor in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation or whether this delivery order was issued against an existing...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $11,509.26 to Amerisourcebergen Drug Corporation for 100 tablets of 2 mg levorphanol. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The order period of performance is August 7-8, 2023. Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products to the Defense Logistics Agency under this small purchase order as a division of its parent company,...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 2mg Levorphanol tablets, a specialty medication, with a ceiling value of $3,753.98 and a period of performance through April 4, 2025. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $6,936.57 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4563492651 - LEVORPHANOL 2 MG TABLET 100S. This delivery order is issued under an existing indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of Levorphanol Tablets, 2mg, a prescription medication, with a Ceiling Value of $8,495.13 and a completion date of April 30, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
- This is a delivery order (DO) contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation. The $1,796.80 firm fixed price contract is for the delivery of 2 mg Levorphanol tablets. This DO is placed against Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of...
- The Defense Logistics Agency awarded a delivery order valued at $1,949.19 to AmerisourceBergen Drug Corp for the supply of Tramadol HCL ER 100 mg tablets in 30-count units. The contract, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at twenty-eight thousand eight dollars to Amerisourcebergen Drug Corporation for the supply of four hundred fifty-six thousand one hundred forty-two thousand three hundred twenty-four levocetirizine five milligram tablets. Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 7, 2023 in support of the Defense Logistics Agency's medical supply...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP45TDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,606.83 to AmerisourceBergen Drug Corp for the supply of Levorphanol 2 mg tablets (100 count) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Levorphanol is an opioid analgesic used for pain management in military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a prime pharmaceutical vendor for the Defense Logistics Agency, AmerisourceBergen Drug Corp serves as a critical supplier of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The company's track record of competitively awarded federal contracts demonstrates its capability to meet stringent federal procurement requirements across multiple therapeutic domains and order sizes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 7/25/25 |